JAYTHARI Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Jaythari, and when can generic versions of Jaythari launch?
Jaythari is a drug marketed by Zydus Lifesciences and is included in one NDA.
The generic ingredient in JAYTHARI is deflazacort. There is one drug master file entry for this compound. Ten suppliers are listed for this compound. Additional details are available on the deflazacort profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Jaythari
A generic version of JAYTHARI was approved as deflazacort by AUROBINDO PHARMA LTD on February 9th, 2024.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for JAYTHARI?
- What are the global sales for JAYTHARI?
- What is Average Wholesale Price for JAYTHARI?
Summary for JAYTHARI
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 3 |
| DailyMed Link: | JAYTHARI at DailyMed |
Pharmacology for JAYTHARI
| Drug Class | Corticosteroid |
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
US Patents and Regulatory Information for JAYTHARI
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zydus Lifesciences | JAYTHARI | deflazacort | TABLET;ORAL | 219254-001 | Apr 8, 2025 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Zydus Lifesciences | JAYTHARI | deflazacort | TABLET;ORAL | 219254-004 | Apr 8, 2025 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Zydus Lifesciences | JAYTHARI | deflazacort | TABLET;ORAL | 219254-002 | Apr 8, 2025 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Zydus Lifesciences | JAYTHARI | deflazacort | TABLET;ORAL | 219254-003 | Apr 8, 2025 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
